A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder.
BACKGROUND
Both psychodynamic group therapy (PGT) and clonazepam are used as treatment strategies in reducing symptoms of generalized social anxiety disorder (GSAD). However, many individuals remain symptomatic after treatment with PGT or clonazepam.


METHODS
Fifty-eight adult outpatients with a diagnosis of GSAD according to DSM-IV were randomized to 12 weeks PGT plus clonazepam or clonazepam. The Clinical Global Impression-Improvement (CGI-I) Scale was the primary efficacy measure. Secondary efficacy measures included the Liebowitz Social Anxiety Scale (LSAS) total score, the World Health Organization Instrument to Assess Quality of Life-Brief (WHOQOL-Bref) Scale and the Beck Depression Inventory (BDI).


RESULTS
CGI-I data from 57 patients (intent-to-treat population) showed that patients who received PGT plus clonazepam presented significantly greater improvement than those who received clonazepam (P=0.033). There were no significant differences between the two groups in the secondary efficacy measures.


CONCLUSIONS
Our study suggests that the combination of PGT with clonazepam may be a promising strategy for the treatment of GSAD, regarding gains in the global functioning. However the present study failed to detect more specific changes in social anxiety symptomatology between the two groups.
Knijnik
Daniela Z
DZ
Psychiatry, School of Medicine, Universidade Federal do Rio Grande do Sul and Anxiety Disorders Program, Hospital de Clínicas de Porto Alegre, Ramiro Barcellos 2350, room 400N, CEP 90035-003, Porto Alegre, RS, Brazil. knijnikd@terra.com.br
Blanco
Carlos
C
Salum
Giovanni Abrahão
GA
Moraes
Carolina U
CU
Mombach
Clarissa
C
Almeida
Ellen
E
Pereira
Marília
M
Strapasson
Atahualpa
A
Manfro
Gisele G
GG
Eizirik
Cláudio L
CL
D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002998:Clonazepam / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009769:Object Attachment; D010552:Personality Assessment; D010698:Phobic Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D010865:Pilot Projects; D011575:Psychoanalytic Therapy; D011615:Psychotherapy, Group; D055815:Young Adult
D014151:Anti-Anxiety Agents; D002998:Clonazepam
Psychiatr Clin North Am. 2001 Dec;24(4):817-29
11723635
Arch Gen Psychiatry. 1998 Dec;55(12):1133-41
9862558
Bull Menninger Clin. 2005 Winter;69(1):1-58
15899755
Can J Psychiatry. 2005 May;50(6):308-16
15999944
Int J Neuropsychopharmacol. 2001 Sep;4(3):279-98
11602035
N Engl J Med. 2006 Sep 7;355(10):1029-36
16957148
Psychopharmacol Bull. 1998;34(2):169-74
9640996
Behav Res Ther. 2002 Jun;40(6):701-15
12051488
Am J Psychother. 2006;60(3):233-59
17066756
J Clin Psychiatry. 2004 Feb;65(2):244-8
15003080
Depress Anxiety. 2003;18(1):29-40
12900950
Am J Psychiatry. 2007 Feb;164(2):265-72
17267789
J Pers Disord. 2003 Dec;17(6):510-21
14744077
Rev Saude Publica. 2000 Apr;34(2):178-83
10881154
Arch Gen Psychiatry. 1961 Jun;4:561-71
13688369
J Clin Psychopharmacol. 2001 Jun;21(3):311-24
11386495
Clin Psychol Rev. 2004 Nov;24(7):883-908
15501560
Arch Gen Psychiatry. 2004 Oct;61(10):1005-13
15466674
Can J Psychiatry. 1987 Mar;32(2):153-5
3567825
Behav Modif. 1998 Jul;22(3):285-97
9670801
JAMA. 2000 May 17;283(19):2529-36
10815116
J Anxiety Disord. 2000 Jul-Aug;14(4):345-58
11043885
Braz J Psychiatry. 2004 Jun;26(2):77-81
15517057
Nord J Psychiatry. 2001;55(6):419-25
11839136
J Affect Disord. 1998 Sep;50 Suppl 1:S17-22
9851574
J Clin Psychiatry. 2005 Feb;66(2):238-47
15705011
J Clin Psychopharmacol. 1993 Dec;13(6):423-8
8120156
Arch Gen Psychiatry. 2004 Dec;61(12):1208-16
15583112
Int J Psychoanal. 2005 Jun;86(Pt 3):841-68
16096078
Am J Psychiatry. 2005 Jan;162(1):151-61
15625214
Int J Group Psychother. 2004 Oct;54(4):491-519
15388403
J Clin Psychopharmacol. 1998 Dec;18(6):429-34
9864073
Depress Anxiety. 2008;25(6):542-53
17941096
Arch Gen Psychiatry. 1987 Mar;44(3):259-64
3548638
Hosp Community Psychiatry. 1983 Dec;34(12):1111-7
6642457
Bull Menninger Clin. 1994 Spring;58(2 Suppl A):A3-20
8044136
Perspect Psychiatr Care. 2002 Jul-Sep;38(3):89-97
12385079
J Clin Psychiatry. 1991 Nov;52 Suppl:16-20
1757453
J Clin Psychiatry. 2006;67 Suppl 12:20-6
17092192
Acta Psychiatr Scand Suppl. 2003;(417):72-84
12950438
Psychol Med. 2001 Aug;31(6):1025-35
11513370
J Clin Psychopharmacol. 1998 Oct;18(5):373-8
9790154
Mod Probl Pharmacopsychiatry. 1987;22:141-73
2885745
J Clin Psychiatry. 2005 Apr;66(4):455-68
15816788
Int J Psychoanal. 2000 Jun;81 ( Pt 3):513-27
10967773
N Engl J Med. 2000 May 18;342(20):1462-70
10816183
Bull Menninger Clin. 1992 Spring;56(2 Suppl A):A3-13
1623339